Major Program
              Supportive Care and Symptom Management
              NCI Community Oncology Research Program
                    Research Group
              Community Oncology and Prevention Trials
                    Sponsor
                    Alliance for Clinical Trials in Oncology
                Status
                    Completed
                NCT ID
                    NCT02229539
                The purpose of this study is to test whether a mouthwash made with a drug called doxepin can reduce the pain caused by mouth sores resulting from radiation therapy. A number of mouth rinse preparations exist for patients with treatment-related oral mucositis pain such as the DLA rinse, an over-the-counter medication. This study will evaluate the effects of doxepin compared to DLA (diphenhydramine, lidocaine and antacids) and placebo.Doxepin is approved by the Food and Drug Administration (FDA) for the treatment of depression, anxiety, long-term pain management, as well as management of rash.
            
  
  
      Intervention
                    DLA (diphenhydramine, lidocaine and antacids) rinse, Placebo, doxepin hydrochloride oral solution
                Condition
                    Acute Oral Mucositis Pain
                Investigators
                    Robert Miller, MD, MS